Seeking Alpha

Teva Pharmaceutical (TEVA +0.3%) says the FDA has approved its Abbreviated New Drug Application...

Teva Pharmaceutical (TEVA +0.3%) says the FDA has approved its Abbreviated New Drug Application for the generic version of Shire's (SHPG) Adderall XR capsules for the treatment of ADD. Adderall XR had annual sales, including brand and generic sales, of approximately $2B in the U.S. last year.
Comments (5)
  • (TEVA) is undervalued.
    14 Feb 2013, 03:36 PM Reply Like
  • It's been "undervalued" for the last several quarters.
    14 Feb 2013, 04:14 PM Reply Like
  • The only loser in my portfolio. Holding and DRIP'ing though, because I think the JV with PG will be a big winner in the long run.
    14 Feb 2013, 04:28 PM Reply Like
  • I think main problem now is the climate surrounding Israel.
    14 Feb 2013, 06:11 PM Reply Like
  • Plus they still have the upcoming Copaxone overhang, and that's a big bit of overall revenues. It's already put pressure on the stock price.
    14 Feb 2013, 06:17 PM Reply Like
DJIA (DIA) S&P 500 (SPY)